Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
McKinsey
Covington
Dow
Federal Trade Commission
Baxter
McKesson
Deloitte

Generated: February 23, 2018

DrugPatentWatch Database Preview

SYNTHROID Drug Profile

« Back to Dashboard

Which patents cover Synthroid, and when can generic versions of Synthroid launch?

Synthroid is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in SYNTHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Drug patent expirations by year for SYNTHROID
Pharmacology for SYNTHROID
Ingredient-typeThyroxine
Drug Classl-Thyroxine

US Patents and Regulatory Information for SYNTHROID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-001 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-007 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-004 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-011 Jul 24, 2002 AB1,AB2 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-008 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-002 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-003 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-006 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-005 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie SYNTHROID levothyroxine sodium TABLET;ORAL 021402-010 Jul 24, 2002 AB1,AB2 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
US Department of Justice
Moodys
Colorcon
Chubb
AstraZeneca
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot